Related Experiment Video
Updated: Jan 9, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Selenium-binding protein 1 suppresses cell cycle progression via cyclin-dependent kinase 2 breakdown in colon
Xiaotian Zhang1, Dong Zhang1, Qichang Liu1
1Department of General Surgery, Shanghai Fifth People's Hospital, Fudan University, Shanghai 200240, PR China.
Abstract:
Selenium-binding protein 1 (SELENBP1) may act as a tumor suppressor gene in colorectal cancer (CRC). However, it remains unclear whether SELENBP1 regulates cell cycle progression governed by cyclin-dependent kinase 2 (CDK2). Herein, we validated the intracellular binding of SELENBP1 to CDK2, based on our previous observations. We investigated the regulatory effects of SELENBP1 on retinoblastoma protein (RB) signaling pathway activation and CDK2-mediated cell cycle progression. Finally, we explored the molecular mechanism through which SELENBP1 inhibited CDK2 expression. Both ectopically induced and endogenously expressed SELENBP1 bound to CDK2 in cultured CRC cells. SELENBP1 inhibited the expression of CDK2 and activated RB signaling. Studies have indicated that SELENBP1 inhibits the cell cycle and suppresses tumor growth. Mechanistic studies showed that SELENBP1 might suppress cancer cell growth by causing CDK2 breakdown via ubiquitination. We conclude that SELENBP1 plays a distinct role as a potential tumor suppressor-associated gene that blocks the interphase and mitosis continuum and suppresses tumor growth in CRC by inducing the ubiquitination-mediated degradation of CDK2.
Insights
Selenium-binding protein 1 (SELENBP1) acts as a tumor suppressor in colorectal cancer by binding to cyclin-dependent kinase 2 (CDK2). SELENBP1 inhibits cancer cell growth by triggering CDK2 degradation, blocking cell cycle progression.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Selenium-binding protein 1 (SELENBP1) is a potential tumor suppressor in colorectal cancer (CRC).
- The role of SELENBP1 in regulating cell cycle progression, specifically involving cyclin-dependent kinase 2 (CDK2), is not fully understood.
Purpose of the Study:
- To investigate the interaction between SELENBP1 and CDK2 in CRC cells.
- To determine how SELENBP1 influences the retinoblastoma protein (RB) signaling pathway and CDK2-mediated cell cycle progression.
- To elucidate the molecular mechanism by which SELENBP1 inhibits CDK2 expression and function.
Main Methods:
- Validation of intracellular binding between SELENBP1 and CDK2 using cultured CRC cells.
- Assessment of SELENBP1's regulatory effects on RB signaling pathway activation.
- Investigation of CDK2-mediated cell cycle progression.
- Exploration of the mechanism underlying SELENBP1-induced inhibition of CDK2 expression, including ubiquitination studies.
Main Results:
- Both ectopically induced and endogenously expressed SELENBP1 were found to bind to CDK2 in CRC cells.
- SELENBP1 inhibited CDK2 expression and activated the RB signaling pathway.
- Mechanistic studies indicated that SELENBP1 promotes CDK2 breakdown via ubiquitination, thereby suppressing cancer cell growth.
Conclusions:
- SELENBP1 functions as a tumor suppressor in colorectal cancer.
- SELENBP1 inhibits cell cycle progression and tumor growth by inducing ubiquitination-mediated degradation of CDK2.
- SELENBP1's mechanism involves blocking the interphase and mitosis continuum, highlighting its potential as a therapeutic target.
Related Concept Videos
Inhibition of Cdk Activity
Negative Regulator Molecules
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Abnormal Proliferation
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Positive Regulator Molecules

